Pfizer & Merck

Paper Summary:

This paper briefly describes changes which have occurred in two of the leading pharmaceutical companies, Merck and Pfizer. These changes have lead to alterations in income and costs. This paper analyzes the years 2002, 2003, and 2004.

From the Paper:

"The pharmaceutical industry is full of changes due to the constant development of new diseases and the fight for cures. As a result, pharmaceutical companies are vigilant in their quest to develop new drugs but it is not only to control or eliminate the disease but also to gain the significant amount of revenue that can be gained if the drug is successful. Regardless whether the company is one of the giants like Pfizer or Merck the fact remains that costs are high which not only incurred for development but also for the testing process. Either way if the drugs are not proven safe and affective, they will not gain the Food and Drug Administration approve and therefore can not be sold. In recent years we have heard much debate on drug costs as well as pharmaceutical company profits."

More papers on Pfizer & Merck:

• Research Proposal # 104178 : "Pfizer Marketing Strategy"
• Analytical Essay # 61299 : "Pfizer"
• Research Proposal # 104133 : "Pfizer's Marketing Strategy"

APA Citation:

MLA Citation: